Expression of Aldehyde Dehydrogenase 1A1 in Relapse-Associated Cells in Acute Myeloid Leukemia
In acute myeloid leukemia (AML) it is important to elucidate the biological events that lead from remission to relapse, which have a high probability of leading to an adverse disease outcome. The cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1A1) is underexpressed in AML cells when compared...
Saved in:
| Main Authors: | Régis Costello, Garrett M. Dancik, Anaïs Dubiau, Lamia Madaci, Spiros Vlahopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/13/1038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II
by: Lokman Varisli, et al.
Published: (2025-01-01) -
Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
by: Alok Gupta, et al.
Published: (2014-01-01) -
Comparative analysis of aldehyde dehydrogenase 1 expression in polyps and adenocarcinoma of the distal colon
by: M.A. Shyshkin, et al.
Published: (2020-12-01) -
Efficacy and safety of mitoxantrone hydrochloride liposome-containing regimens in treating refractory/relapsed acute myeloid leukemia
by: Ni Lu, et al.
Published: (2025-05-01) -
Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia
by: Jiawen Wang, et al.
Published: (2025-12-01)